Research Article

Levels of CEACAM6 in Peripheral Blood Are Elevated in Patients with Plasma Cell Disorders: A Potential New Diagnostic Marker and a New Therapeutic Target?

Table 2

CEACAM6 levels in peripheral blood are increasing from healthy controls to MGUS/MM pts.

PatientsCEACAM6 levelsCEACAM6 levelsCEACAM6 levels value
Median (pg/ml)95% CIIQR

Healthy con. ()15.213.8–16.312.1–17.1
MGUS ()19.016.9–20.616.4–22.5
NDMM ()18.016.2–19.813.4–21.2
RRMM ()18.916.9–22.216.5–24.1
All pts. ()17.316.4–18.416.4–18.4

Healthy con.: healthy controls; MGUS: monoclonal gammopathy of undetermined significance; MM: multiple myeloma; NDMM: newly diagnosed multiple myeloma; RRMM: relapsed/refractory multiple myeloma; IQR: interquartile range.